<DOC>
	<DOCNO>NCT00478881</DOCNO>
	<brief_summary>The purpose study ass study drug , Vardenafil ( approve Health Authorities available market treatment erectile dysfunction ) effect bladder function micturition frequency . The study drug take form tablet twice day , one tablet morning one tablet evening . A non-active treatment ( placebo ) , sugar pill , use comparator see new study drug work well drug . The timing visit study follow : 1st visit ( screen visit ) begin run-in-assessment qualifying test patient : electrocardiogram ( ECG ) , safety laboratory residual urine ( ultrasonography : non-invasive examination use ultrasound assessment bladder ) . 2nd visit ( randomization visit ) . During visit perform : urodynamic measurement ( fill cystometry pressure flow investigation ) , ECG safety laboratory . 3rd visit ( safety visit ) take place two three week randomize treatment . 4th visit ( final visit ) -following test do : urodynamic measurement ( fill cystometry pressure flow investigation ) , ECG , safety laboratory residual urine ( ultrasonography ) ; A phone call 24 hour visit 4 assess SAEs .</brief_summary>
	<brief_title>A Study To Assess If 10 mg Vardenafil ( BAY38-9456 ) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Male female patient age &gt; 18 year ( female either postmenopausal use adequate birth control ) Urodynamic criterion : Entire bladder capacity ( = maximum cystometric bladder capacity ) &lt; 300 mL OR In accordance International Continence Society ( ICS ) guideline : Detrusor overactivity define spontaneous involuntary detrusor contraction fill phase OR Detrusor contraction fill phase lead involuntarily initiate micturition normal bladder capacity reach Patient micturition diary criterion : least 8 micturition per day AND least 1 urgency episode per day Signed date write Patient Informed Consent Form Treatment drug know affect urinary bladder function Known reason micturition problem detrusor overactivity Recent intervention urogenital tract Abnormal liver renal lab value Treatment nitrate nitric oxide donor , alphablockers , potent inhibitor CYP450 3A4 , acenocoumarol , heparin , drug know prolong QTinterval NAION , hereditary regenerative retinal disorder , severe cardiovascular condition , recent history myocardial infarction/stroke/lifethreatening arrhythmia congenital QTprolongation , leave ventricular outflow obstruction , severe hypo hypertension , symptomatic postural hypotension History positive test Hepatitis B surface antigen ( HBsAg ) Hepatitis C Significant active peptic ulceration Severe chronic acute liver disease , history moderate ( ChildPugh B ) severe ( ChildPugh C ) hepatic impairment In men : Clinically significant chronic haematological disease may lead priapism History malignancy organ system within past 5 year Bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>